Shared investments between research institutions and the government are essential for the health, prosperity and future of ...
The 15th rendition of RootsTech looks to not only cater to thousands of in-person attendees but also meet the needs of a mass ...
In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...
Piper Sandler lowered the firm’s price target on Myriad Genetics (MYGN) to $11.50 from $14 following quarterly results. The firm keeps a ...